As of 2024-07-27, the Fair Value of Helix Biopharma Corp (HBP.TO) is -0.13 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.27 CAD, the upside of Helix Biopharma Corp is -149.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 5Y Avg | |
| Net income | -7.53 | -8.99 | -8.04 | -6.56 | -6.29 | -7.48 |
| YoY growth | 12.75% | -19.39% | 10.59% | 18.34% | 4.17% | 5.29% |
| Market Cap (mil) | 66.18 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | 5.29% |
| TTM earnings | -6.14 |